Inventor · disambiguated record
Vanessa Legry
Also filed as: LEGRY VANESSA
3 granted patents·4 pending applications·20 citations·filing 2018–2022
65Inventor score
Files withGENFIT7
Top patents by PatentIndex Score
7 records- 0191US11478440B2Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agentGENFIT·Filed 2018·Granted Oct 25, 2022·10 cites·3 claims
- 0286US11484517B2Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitorGENFIT·Filed 2018·Granted Nov 1, 2022·10 cites·2 claims
- 0358US2024216313A1Elafibranor derivatives agonists of ppar for use in the treatment of sepsisGENFIT·Filed 2022·Application pending·0 cites
- 0458US2024216312A1Ppar-agonists for use in the treatment of liver failureGENFIT·Filed 2022·Application pending·0 cites
- 0558US2024238256A1Nitazoxanide in the treatment of sepsisGENFIT·Filed 2022·Application pending·0 cites
- 0655US2024000754A1Methods of treatment of liver failureGENFIT·Filed 2021·Application pending·0 cites
- 0749US12458612B2Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonistsGENFIT·Filed 2020·Granted Nov 4, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Vanessa Legry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →